European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 Update;Guía clínica para el diagnóstico y tratamiento de los carcinomas de las células uroteliales de las vías urinarias superiores: actualización de 2011

Actas Urologicas Espanolas

Volumn 36, Issue 1, 2012, Pages 2-14

  Roupret M ^a   Zigeuner, R ^b   Palou, J ^c   Boehle, A ^d   Kaasinen, E ^e   Sylvester, R ^f   Babjuk, M ^g   Oosterlinck, W ^h  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c FUNDACIÓ PUIGVERT   (Spain)

^d Hospital HELIOS Agnes Karll   (Germany)

^e Hospital of Hyvinkää   (Finland)

^f Organización Europea Para la Investigación y El Tratamiento Del Cáncer   (Belgium)

^g CHARLES UNIVERSITY   (Czech Republic)

^h GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Guidelines; Laparoscopy; Nephroureterectomy; Prognosis; Renal pelvis; Ureter; Ureteroscopy; Urinary markers; Urothelial carcinoma

Indexed keywords

BCG VACCINE; MITOMYCIN; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; DIAGNOSTIC IMAGING; EVIDENCE BASED MEDICINE; HUMAN; KIDNEY TUMOR; LAPAROSCOPY; METHODOLOGY; NEPHRECTOMY; PATHOLOGY; PERCUTANEOUS NEPHROSTOMY; PRACTICE GUIDELINE; PROGNOSIS; RISK FACTOR; TRANSITIONAL CELL CARCINOMA; URETER TUMOR; URETEROSCOPY;

BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; DIAGNOSTIC IMAGING; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY NEOPLASMS; LAPAROSCOPY; MITOMYCIN; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPHRECTOMY; NEPHROSTOMY, PERCUTANEOUS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; URETERAL NEOPLASMS; URETEROSCOPY;

EID: 84855438472     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2011.09.001     Document Type: Article

References (118)

1. W. Oosterlinck, E. Solsona, A.P. Van der Meijden, R. Sylvester, A. Böhle, and E. Rintala EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma Eur Urol 46 2004 147 154 http://www.ncbi.nlm.nih.gov/pubmed/15245806 (Pubitemid 38902728)
2. Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based Medicine - levels of evidence (March 2009). Centre for Evidence Based Medicine Web site. Disponible en: http://www.cebm.net/index.aspx?o=1025 (actualizado en marzo de 2009).
3. J.J. Munoz, and L.M. Ellison Upper tract urothelial neoplasms: incidence and survival during the last 2 decades J Urol 164 2000 1523 1525 http://www.ncbi.nlm.nih.gov/pubmed/11025695
4. M. Ploeg, K.K. Aben, and L.A. Kiemeney The present and future burden of urinary bladder cancer in the world World J Urol 27 2009 289 293 http://www.ncbi.nlm.nih.gov/pubmed/19219610
5. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou-Redorta European Association of Urology (EAU) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 54 2008 303 314 http://www.ncbi.nlm.nih.gov/pubmed/18468779
6. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249 http://www.ncbi.nlm.nih.gov/ pubmed/19474385
7. M.C. Hall, S. Womack, A.I. Sagalowsky, T. Carmody, M.D. Erickstad, and C.G. Roehrborn Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients Urology 52 1998 594 601 http://www.ncbi.nlm.nih.gov/pubmed/9763077 (Pubitemid 28440164)
8. V. Margulis, S.F. Shariat, S.F. Matin, A.M. Kamat, R. Zigeuner, and E. Kikuchi Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration Cancer 115 2009 1224 1233 http://www.ncbi.nlm.nih.gov/pubmed/19156917
9. S. Olgac, M. Mazumdar, G. Dalbagni, and V.E. Reuter Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases Am J Surg Pathol 28 2004 1545 1552 http://www.ncbi.nlm.nih.gov/pubmed/15577672 (Pubitemid 39564958)
10. M.D. Azemar, E. Comperat, F. Richard, O. Cussenot, and M. Rouprêt Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance Urol Oncol 29 2001 130 136 http://www.ncbi.nlm.nih.gov/pubmed/19762256
11. J.D. Raman, C.K. Ng, D.S. Scherr, V. Margulis, Y. Lotan, and K. Bensalah Impact of Tumor Location on Prognosis for Patients with Upper Tract Urothelial Carcinoma Managed by Radical Nephroureterectomy Eur Urol 57 2010 1072 1093 http://www.ncbi.nlm.nih.gov/pubmed/19619934
12. W.M. Li, J.T. Shen, C.C. Li, H.L. Ke, Y.C. Wei, and W.J. Wu Oncologic Outcomes Following Three Different Approaches to the Distal Ureter and Bladder Cuff in Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma Eur Urol 57 2010 963 969 http://www.ncbi.nlm.nih.gov/pubmed/20079965
13. G. Novara, V. De Marco, O. Dalpiaz, A. Galfano, V. Bouygues, and M. Gardiman Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers Int J Urol 16 2009 187 191 http://www.ncbi.nlm.nih.gov/pubmed/19054165
14. M. Rouprêt, J. Catto, F. Coulet, A.R. Azzouzi, N. Amira, and T. Karmouni Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma J Med Genet 41 2004 e91 http://www.ncbi.nlm.nih.gov/pubmed/15235034
15. P. Acher, G. Kiela, K. Thomas, and T. O'Brien Towards a rational strategy for the surveillance of patients with Lynch syndrome (hereditary non-polyposis colon cancer) for upper tract transitional cell carcinoma BJU Int 106 2010 300 302 http://www.ncbi.nlm.nih.gov/pubmed/20553255
16. M. Rouprêt, D.R. Yates, E. Comperat, and O. Cussenot Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum Eur Urol 54 2008 1226 1236 http://www.ncbi.nlm.nih.gov/pubmed/18715695
17. P. Colin, P. Koenig, A. Ouzzane, N. Berthon, A. Villers, and J. Biserte Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract BJU Int 104 2009 1436 1440 http://www.ncbi.nlm.nih. gov/pubmed/19689473
18. W. Pommer, E. Bronder, A. Klimpel, U. Helmert, E. Greiser, and M. Molzahn Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study Nephrol Dial Transplant 14 1999 2892 2897 http://www.ncbi.nlm.nih.gov/ pubmed/10570093
19. T. Shinka, M. Miyai, Y. Sawada, T. Inagaki, and T. Okawa Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines Int J Urol 2 1995 243 248 http://www.ncbi.nlm.nih.gov/pubmed/8564742
20. N. Markovic, I. Ignjatovic, R. Cukuranovic, B. Petrovic, B. Kocic, and V. Stefanovic Decreasing incidence of urothelial cancer in a Balkan endemic nephropathy region in Serbia. A surgery based study from 1969 to 1998 Pathol Biol (Paris) 53 2005 26 29 http://www.ncbi.nlm.nih.gov/pubmed/15620606 (Pubitemid 40037251)
21. A.P. Grollman, S. Shibutani, M. Moriya, F. Miller, L. Wu, and U. Moll Aristolochic acid and the etiology of endemic (Balkan) nephropathy Proc Natl Acad Sci U S A 104 2007 12129 12134 http://www.ncbi.nlm.nih.gov/pubmed/17620607 (Pubitemid 47185641)
22. V.M. Arlt, M. Stiborova, J. vom Brocke, M.L. Simões, G.M. Lord, and J.L. Nortier Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer Carcinogenesis 28 2007 2253 2261 http://www.ncbi.nlm.nih.gov/pubmed/17434925 (Pubitemid 350111583)
23. C. Laing, S. Hamour, M. Sheaff, R. Miller, and R. Woolfson Chinese herbal uropathy and nephropathy Lancet 368 2006 338 http://www.ncbi.nlm.nih.gov/ pubmed/16860704 (Pubitemid 44067250)
24. G.M. Lord, T. Cook, V.M. Arlt, H.H. Schmeiser, G. Williams, and C.D. Pusey Urothelial malignant disease and Chinese herbal nephropathy Lancet 358 2001 1515 1516 http://www.ncbi.nlm.nih.gov/pubmed/11705569 (Pubitemid 33055708)
25. L.B. Tan, K.T. Chen, and H.R. Guo Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan BJU Int 102 2008 48 54 http://www.ncbi.nlm.nih.gov/pubmed/18445081
26. M. Rouprêt, G. Cancel-Tassin, E. Comperat, G. Fromont, M. Sibony, and V. Molinié Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma Cancer Epidemiol Biomarkers Prev 16 2007 2500 2503 http://www.ncbi.nlm.nih.gov/pubmed/18006944 (Pubitemid 351196388)
27. D. Perez-Montiel, P.E. Wakely, O. Hes, M. Michal, and S. Suster High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants Mod Pathol 19 2006 494 503 http://www.ncbi.nlm.nih.gov/pubmed/16474378
28. G.D. Stewart, S.V. Bariol, K.M. Grigor, D.A. Tolley, and S.A. McNeill A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract BJU Int 95 2005 791 793 http://www.ncbi.nlm.nih.gov/pubmed/ 15794784 (Pubitemid 40547208)
29. A. Orsola, I. Trias, C.X. Raventos, I. Español, L. Cecchini, and I. Orsola Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma Urology 65 2005 49 54 http://www.ncbi.nlm.nih.gov/pubmed/15667862 (Pubitemid 40169604)
30. J.E. Busby, G.A. Brown, P. Tamboli, A.M. Kamat, C.P. Dinney, and H.B. Grossman Upper urinary tract tumors with nontransitional histology: a single-center experience Urology 67 2006 518 523 http://www.ncbi.nlm.nih.gov/ pubmed/16527570 (Pubitemid 43343533)
31. Sobin L, Gospodarowicz M, Wittekind C. TNM Classification of Malignant Tumours. Urological Tumours. Renal Pelvis and Ureter. 7th revised edition Wiley-Blackwell, uicc; 2009. p. 258-261 http://www.uicc.org/tnm
32. A. Lopez-Beltran, P. Bassi, and M. Pavone-Macaluso Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis Eur Urol 45 2004 257 266 http://www.ncbi.nlm.nih.gov/pubmed/15036668 (Pubitemid 38221396)
33. G. Sauter, F. Algaba, and M. Amin Tumors of the urinary system in: World Health Organisation classification of tumors. Pathology and genetics of tumors of the urinary system and male genital organs 2004 IARC Press Lyon, Francia p. 110-123
34. Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M, et al. Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol. 2010. doi: 10.1016/j.urolonc.2009.11.007. http://www.ncbi.nlm.nih.gov/pubmed/20056458
35. J.R. Dillman, E.M. Caoili, R.H. Cohan, J.H. Ellis, I.R. Francis, and M.J. Schipper Detection of upper tract urothelial neoplasms: sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urography Abdom Imaging 33 2008 707 716 http://www.ncbi.nlm. nih.gov/pubmed/18253780
36. A.J. Van Der Molen, N.C. Cowan, U.G. Mueller-Lisse, C.C. Nolte-Ernsting, S. Takahashi, and R.H. Cohan CT urography: definition, indications and techniques. A guideline for clinical practice Eur Radiol 18 2008 4 17 http://www.ncbi.nlm.nih.gov/pubmed/17973110
37. L.J. Wang, Y.C. Wong, C.K. Chuang, C.C. Huang, and S.T. Pang Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria J Urol 181 2009 524 531 discussion 531 http://www.ncbi.nlm.nih.gov/pubmed/19100576
38. L.J. Wang, Y.C. Wong, C.C. Huang, C.H. Wu, S.C. Hung, and H.W. Chen Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria J Urol 183 2010 48 55 http://www.ncbi.nlm.nih.gov/ pubmed/19913253
39. C.K. Ng, S.F. Shariat, S.M. Lucas, A. Bagrodia, Y. Lotan, and D.S. Scherr Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? Urol Oncol 29 2011 27 32 http://www.ncbi.nlm.nih.gov/ pubmed/19117771
40. N. Takahashi, J.F. Glockner, R.P. Hartman, B.F. King, B.C. Leibovich, and D.W. Stanley Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy J Urol 183 2010 1330 1365 http://www.ncbi.nlm.nih.gov/pubmed/ 20171676
41. N. Takahashi, A. Kawashima, J.F. Glockner, R.P. Hartman, B.C. Leibovich, and A.C. Brau Small (< 2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography Radiology 247 2008 451 457 http://www.ncbi.nlm.nih.gov/pubmed/18372452
42. J.C. Brien, S.F. Shariat, M.P. Herman, C.K. Ng, D.S. Scherr, and B. Scoll Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma J Urol 184 2010 69 73 http://www.ncbi.nlm.nih.gov/pubmed/20478585
43. B. Luo, W. Li, C.H. Deng, F.F. Zheng, X.Z. Sun, and D.H. Wang Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma Cancer Genet Cytogenet 189 2009 93 97 http://www.ncbi.nlm. nih.gov/pubmed/19215789
44. C. Mian, G. Mazzoleni, S. Vikoler, T. Martini, R. Knüchel-Clark, and D. Zaak Fluorescence In Situ Hybridisation in the Diagnosis of Upper Urinary Tract Tumours Eur Urol 58 2010 288 292 http://www.ncbi.nlm.nih.gov/pubmed/ 20471154
45. A.M. Nieder, M.S. Soloway, and H.W. Herr Should we abandon the FISH test? Eur Urol 51 2007 1469 1471 http://www.ncbi.nlm.nih.gov/pubmed/17257740 (Pubitemid 46634755)
46. J.R. Johannes, E. Nelson, M. Bibbo, and D.H. Bagley Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance J Urol 184 2010 879 882 http://www.ncbi.nlm.nih.gov/pubmed/20643443
47. A.A. Chen, and M. Grasso Is there a role for FISH in the management and surveillance of patients with upper tract transitional-cell carcinoma? J Endourol 22 2008 1371 1374 http://www.ncbi.nlm.nih.gov/pubmed/18578665 (Pubitemid 351913508)
48. K.S. Lee, E. Zeikus, W.C. DeWolf, N.M. Rofsky, and I. Pedrosa MR urography versus retrograde pyelography/ureteroscopy for the exclusion of upper urinary tract malignancy Clin Radiol 65 2010 185 192 http://www.ncbi.nlm.nih. gov/pubmed/20152273
49. S. Ishikawa, T. Abe, N. Shinohara, T. Harabayashi, A. Sazawa, and S. Maruyama Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract J Urol 184 2010 883 887 http://www.ncbi.nlm.nih.gov/pubmed/20643446
50. F. Tavora, D.A. Fajardo, T.K. Lee, T. Lotan, J.S. Miller, and H. Miyamoto Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls Am J Surg Pathol 33 2009 1540 1546 http://www.ncbi.nlm.nih.gov/pubmed/19654502
51. R. Abouassaly, S.M. Alibhai, N. Shah, N. Timilshina, N. Fleshner, and A. Finelli Troubling Outcomes From Population-level Analysis of Surgery for Upper Tract Urothelial Carcinoma Urology 76 2010 895 901 http://www.ncbi.nlm.nih.gov/ pubmed/20646743
52. C. Jeldres, M. Sun, H. Isbarn, G. Lughezzani, L. Budäus, and A. Alasker A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma Urology 75 2010 315 320 http://www.ncbi.nlm.nih.gov/pubmed/19963237
53. C. Langner, G. Hutterer, T. Chromecki, I. Winkelmayer, P. Rehak, and R. Zigeuner pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract Mod Pathol 19 2006 272 279 http://www.ncbi.nlm.nih.gov/pubmed/16424895 (Pubitemid 43117612)
54. J. Lehmann, H. Suttmann, I. Kovac, M. Hack, J. Kamradt, and S. Siemer Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival Eur Urol 51 2007 1281 1288 http://www.ncbi.nlm.nih.gov/ pubmed/17125909 (Pubitemid 46436299)
55. C.C. Li, T.H. Chang, W.J. Wu, H.L. Ke, S.P. Huang, and P.C. Tsai Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients Eur Urol 54 2008 1127 1134 http://www.ncbi.nlm.nih.gov/pubmed/18243511
56. M.I. Fernández, S.F. Shariat, V. Margulis, C. Bolenz, F. Montorsi, and N. Suardi Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study Urology 73 2009 142 146 http://www.ncbi.nlm.nih.gov/pubmed/ 18845322
57. G. Lughezzani, M. Sun, P. Perrotte, S.F. Shariat, C. Jeldres, and L. Budäus Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database Urology 75 2010 321 327 http://www.ncbi.nlm.nih.gov/pubmed/ 19962727
58. S.F. Shariat, R.L. Favaretto, A. Gupta, H.M. Fritsche, K. Matsumoto, and W. Kassouf Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma World J Urol 29 2011 481 486
59. S.F. Shariat, G. Godoy, Y. Lotan, M. Droller, P.I. Karakiewicz, and J.D. Raman Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy BJU Int 105 2010 1672 1677 http://www.ncbi.nlm. nih.gov/pubmed/19912201
60. R.L. Favaretto, S.F. Shariat, D.C. Chade, G. Godoy, A. Adamy, and M. Kaag The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer Center Eur Urol 58 2010 574 580 http://www.ncbi.nlm.nih.gov/pubmed/20637540
61. H. Isbarn, C. Jeldres, S.F. Shariat, D. Liberman, M. Sun, and G. Lughezzani Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma J Urol 182 2009 2177 2181 http://www.ncbi.nlm.nih.gov/pubmed/19758662
62. H.G. Van der Poel, N. Antonini, H. Van Tinteren, and S. Horenblas Upper urinary tract cancer: location is correlated with prognosis Eur Urol 48 2005 438 444 http://www.ncbi.nlm.nih.gov/pubmed/16115524 (Pubitemid 41188399)
63. V. Margulis, R.F. Youssef, P.I. Karakiewicz, Y. Lotan, C.G. Wood, and R. Zigeuner Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract J Urol 184 2010 453 458 http://www.ncbi.nlm.nih.gov/pubmed/20620397
64. E. Kikuchi, V. Margulis, P.I. Karakiewicz, M. Roscigno, S. Mikami, and Y. Lotan Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma J Clin Oncol 27 2009 612 628 http://www.ncbi.nlm.nih.gov/pubmed/19075275
65. D.S. Kim, Y.H. Lee, K.S. Cho, N.H. Cho, B.H. Chung, and S.J. Hong Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma Urology 75 2010 328 332 http://www.ncbi.nlm.nih.gov/pubmed/ 20018349
66. G. Novara, K. Matsumoto, W. Kassouf, T.J. Walton, H.M. Fritsche, and P.J. Bastian Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract: An International Validation Study Eur Urol 57 2010 1064 1071 http://www.ncbi.nlm.nih.gov/pubmed/20071073
67. R. Zigeuner, S.F. Shariat, V. Margulis, P.I. Karakiewicz, M. Roscigno, and A. Weizer Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract Eur Urol 57 2010 575 581 http://www.ncbi.nlm.nih.gov/pubmed/19959276
68. C. Seitz, A. Gupta, S.F. Shariat, K. Matsumoto, W. Kassouf, and T.J. Walton Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study J Urol 184 2010 1895 1900 http://www.ncbi.nlm.nih.gov/pubmed/20846680
69. M. Remzi, A. Haitel, V. Margulis, P. Karakiewicz, F. Montorsi, and E. Kikuchi Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients BJU Int 103 2009 307 311 http://www.ncbi.nlm.nih.gov/pubmed/18990163
70. Wheat JC, Weizer AZ, Wolf JS, Jr., Lotan Y, Remzi M, Margulis, et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol. 2010. doi:10.1016/j.urolonc.2010.01.001. http://www.ncbi.nlm.nih. gov/pubmed/20451416
71. E. Pieras, G. Frontera, X. Ruiz, A. Vicens, M. Ozonas, and P. Pizá Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma BJU Int 106 2010 1319 1323 http://www.ncbi.nlm.nih.gov/pubmed/20394618
72. M. Rouprêt, G. Fromont, A.R. Azzouzi, J.W. Catto, G. Vallancien, and F.C. Hamdy Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma Urology 65 2005 1233 1237 http://www.ncbi.nlm.nih.gov/pubmed/15922421 (Pubitemid 40824937)
73. S. Eltz, E. Comperat, O. Cussenot, and M. Rouprêt Molecular and histological markers in urothelial carcinomas of the upper urinary tract BJU Int 102 2008 532 535 http://www.ncbi.nlm.nih.gov/pubmed/18384628
74. G. Lughezzani, M. Sun, P. Perrotte, S.F. Shariat, C. Jeldres, and L. Budaus Should Bladder Cuff Excision Remain the Standard of Care at Nephroureterectomy in Patients with Urothelial Carcinoma of the Renal Pelvis?. A Population-based Study Eur Urol 57 2010 956 962 http://www.ncbi.nlm.nih.gov/ pubmed/20018438
75. T. Saika, J. Nishiguchi, T. Tsushima, Y. Nasu, A. Nagai, and Y. Miyaji Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy? BJU Int 108 2011 130 138 http://www.ncbi.nlm. nih.gov/pubmed/21070580
76. R. Zigeuner, and K. Pummer Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors Eur Urol 53 2008 720 731 http://www.ncbi.nlm.nih.gov/pubmed/18207315
77. T. Saika, J. Nishiguchi, T. Tsushima, Y. Nasu, A. Nagai, and Y. Miyaji Comparative study of ureteral stripping versus open ureterectomy for nephroureterectomy in patients with transitional carcinoma of the renal pelvis Urology 63 2004 848 852 http://www.ncbi.nlm.nih.gov/pubmed/15134963 (Pubitemid 38596663)
78. J. Palou, J. Caparrós, A. Orsola, B. Xavier, and J. Vicente Transurethral resection of the intramural ureter as the first step of nephroureterectomy J Urol 154 1995 43 44 http://www.ncbi.nlm.nih.gov/pubmed/ 7776453
79. M.P. Laguna, and J.J. De la Rosette The endoscopic approach to the distal ureter in nephroureterectomy for upper urinary tract tumor J Urol 166 2001 2017 2022 http://www.ncbi.nlm.nih.gov/pubmed/11696698 (Pubitemid 33065208)
80. M. Waldert, P.I. Karakiewicz, J.D. Raman, M. Remzi, H. Isbarn, and Y. Lotan A delay in radical nephroureterectomy can lead to upstaging BJU Int 105 2010 812 817 http://www.ncbi.nlm.nih.gov/pubmed/19732052
81. G. Lughezzani, C. Jeldres, H. Isbarn, S.F. Shariat, M. Sun, and D. Pharand A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma Urology 75 2010 118 124 http://www.ncbi.nlm.nih.gov/pubmed/19864000
82. M. Roscigno, S.F. Shariat, V. Margulis, P. Karakiewicz, M. Remzi, and E. Kikuchi Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy J Urol 181 2009 2482 2489 http://www.ncbi.nlm.nih.gov/pubmed/19371878
83. M. Roscigno, S.F. Shariat, V. Margulis, P. Karakiewicz, M. Remzi, and E. Kikuchi The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 56 2009 512 518 http://www.ncbi.nlm.nih.gov/pubmed/19559518
84. A. Berger, G.P. Haber, K. Kamoi, M. Aron, M.M. Desai, and J.H. Kaouk Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years J Urol 180 2008 849 854 discussion 854 http://www.ncbi.nlm.nih.gov/pubmed/18635229
85. J.J. Rassweiler, M. Schulze, R. Marrero, T. Frede, J. Palou Redorta, and P. Bassi Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery? Eur Urol 46 2004 690 697 http://www.ncbi.nlm.nih.gov/pubmed/15548434 (Pubitemid 39488397)
86. A.M. Ong, S.B. Bhayani, and C.P. Pavlovich Trocar site recurrence after laparoscopic nephroureterectomy J Urol 170 4 Pt 1 2003 1301 http://www.ncbi.nlm. nih.gov/pubmed/14501747 (Pubitemid 37108138)
87. M. Rouprêt, G. Smyth, J. Irani, L. Guy, J.L. Davin, and F. Saint Oncological risk of laparoscopic surgery in urothelial carcinomas World J Urol 27 2009 81 88 http://www.ncbi.nlm.nih.gov/pubmed/19020880
88. U. Capitanio, S.F. Shariat, H. Isbarn, A. Weizer, M. Remzi, and M. Roscigno Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases Eur Urol 56 2009 1 9 http://www.ncbi.nlm.nih.gov/pubmed/19361911
89. R.L. Favaretto, S.F. Shariat, D.C. Chade, G. Godoy, M. Kaag, and A.M. Cronin Comparison Between Laparoscopic and Open Radical Nephroureterectomy in a Contemporary Group of Patients: Are Recurrence and Disease-Specific Survival Associated with Surgical Technique? Eur Urol 58 2010 645 651 http://www.ncbi.nlm.nih.gov/pubmed/20724065
90. O. Kamihira, R. Hattori, A. Yamaguchi, G. Kawa, O. Ogawa, and T. Habuchi Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan Eur Urol 55 2009 1397 1407 http://www.ncbi.nlm.nih.gov/pubmed/19299072
91. M. Rouprêt, V. Hupertan, K.M. Sanderson, J.D. Harmon, X. Cathelineau, and E. Barret Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience Urology 69 2007 656 661 http://www.ncbi.nlm.nih.gov/pubmed/ 17445646 (Pubitemid 46584731)
92. G. Simone, R. Papalia, S. Guaglianone, M. Ferriero, C. Leonardo, and E. Forastiere Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study Eur Urol 56 2009 520 526 http://www.ncbi.nlm.nih.gov/pubmed/19560259
93. G.L. Chen, and D.H. Bagley Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys J Urol 164 2000 1173 1176 http://www.ncbi.nlm.nih.gov/pubmed/10992360
94. A.J. Gadzinski, W.W. Roberts, G.J. Faerber, and J.S. Wolf Jr. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma J Urol 183 2010 2148 2153 http://www.ncbi.nlm.nih.gov/ pubmed/20399468
95. G.A. Brown, J.E. Busby, C.G. Wood, L.L. Pisters, C.P. Dinney, and D.A. Swanson Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int 98 2006 1176 1180 http://www.ncbi.nlm.nih.gov/pubmed/17125474 (Pubitemid 44721220)
96. D.H. Bagley, and M. Grasso 3rd. Ureteroscopic laser treatment of upper urinary tract neoplasms World J Urol 28 2010 143 149 http://www.ncbi.nlm.nih. gov/pubmed/20229233
97. M. Rouprêt, V. Hupertan, O. Traxer, G. Loison, E. Chartier-Kastler, and P. Conort Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma Urology 67 2006 1181 1187 http://www.ncbi.nlm.nih.gov/pubmed/16765178 (Pubitemid 43833463)
98. J.N. Cornu, M. Rouprêt, X. Carpentier, B. Geavlete, S.G. de Medina, and O. Cussenot Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma World J Urol 28 2010 151 156 http://www.ncbi.nlm.nih.gov/pubmed/20044752
99. M. Rouprêt, H. Wallerand, O. Traxer, C. Roy, C. Mazerolles, and F. Saint Checkup and management of upper urinary tract tumours in 2010: An update from the committee of cancer from the French National Association of Urology Prog Urol 20 2010 260 271 http://www.ncbi.nlm.nih.gov/pubmed/20380988
100. C. Jeldres, G. Lughezzani, M. Sun, H. Isbarn, S.F. Shariat, and L. Budaus Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter J Urol 183 2010 1324 1329 http://www.ncbi.nlm.nih. gov/pubmed/20171666
101. R.H. Thompson, A.E. Krambeck, C.M. Lohse, D.S. Elliott, D.E. Patterson, and M.L. Blute Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract BJU Int 102 2008 1107 1110 http://www.ncbi.nlm.nih.gov/pubmed/18522631
102. E. Zungri, G. Chéchile, F. Algaba, I. Diaz, F. Vilá, and C. Castro Treatment of transitional cell carcinoma of the ureter: is the controversy justified? Eur Urol 17 1990 276 280 http://www.ncbi.nlm.nih.gov/ pubmed/2364964 (Pubitemid 20182243)
103. J. Palou, L.F. Piovesan, J. Huguet, J. Salvador, J. Vicente, and H. Villavicencio Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup J Urol 172 2004 66 69 http://www.ncbi.nlm.nih.gov/pubmed/15201739 (Pubitemid 41615040)
104. M. Rouprêt, O. Traxer, M. Tligui, P. Conort, E. Chartier-Kastler, and F. Richard Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection Eur Urol 51 2007 709 713 discussion 714 http://www.ncbi.nlm.nih.gov/pubmed/16911852
105. A. Irie, M. Iwamura, K. Kadowaki, A. Ohkawa, T. Uchida, and S. Baba Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter Urology 59 2002 53 57 http://www.ncbi.nlm. nih.gov/pubmed/11796281 (Pubitemid 34059307)
106. N. Nonomura, Y. Ono, M. Nozawa, T. Fukui, Y. Harada, and K. Nishimura Bacillus Calmette-Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract Eur Urol 38 2000 701 704 discussion 705 http://www.ncbi.nlm.nih.gov/pubmed/11111187
107. G.N. Thalmann, R. Markwalder, B. Walter, and U.E. Studer Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery J Urol 168 4 Pt 1 2002 1381 1385 http://www.ncbi.nlm.nih.gov/pubmed/12352398 (Pubitemid 35034127)
108. Audenet F, Yates D, Cussenot O, Rouprêt M. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC). Urol Oncol. 2010. doi:10.1016/j.urolonc.2010.07.016. http://www.ncbi.nlm.nih.gov/pubmed/20884249.
109. N.J. Hellenthal, S.F. Shariat, V. Margulis, P.I. Karakiewicz, M. Roscigno, and C. Bolenz Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration J Urol 182 2009 900 906 http://www.ncbi.nlm.nih.gov/pubmed/ 19616245
110. M.G. Kaag, R.L. O'Malley, P. O'Malley, G. Godoy, M. Chen, and M.C. Smaldone Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy Eur Urol 58 2010 581 587 http://www.ncbi.nlm. nih.gov/pubmed/20619530
111. B.R. Lane, A.K. Smith, B.T. Larson, M.C. Gong, S.C. Campbell, and D. Raghavan Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy Cancer 116 2010 2967 2973 http://www.ncbi.nlm.nih.gov/pubmed/ 20564402
112. S.F. Matin, V. Margulis, A. Kamat, C.G. Wood, H.B. Grossman, and G.A. Brown Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma Cancer 116 2010 3127 3134 http://www.ncbi.nlm.nih.gov/pubmed/20564621
113. M.C. Hall, J.S. Womack, C.G. Roehrborn, T. Carmody, and A.I. Sagalowsky Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy J Urol 160 3 Pt 1 1998 703 706 http://www.ncbi.nlm.nih.gov/pubmed/9720526 (Pubitemid 29479492)
114. B. Czito, A. Zietman, D. Kaufman, U. Skowronski, and W. Shipley Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter J Urol 172 4 Pt 1 2004 1271 1275 http://www.ncbi.nlm.nih.gov/pubmed/15371822 (Pubitemid 39249696)
115. J.D. Raman, C.K. Ng, S.A. Boorjian, E.D. Vaughan Jr., R.E. Sosa, and D.S. Scherr Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology BJU Int 96 2005 1031 1035 http://www.ncbi.nlm.nih.gov/pubmed/16225523 (Pubitemid 41531409)
116. T. Terakawa, H. Miyake, M. Muramaki, A. Takenaka, I. Hara, and M. Fujisawa Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract Urology 71 2008 123 127 http://www.ncbi.nlm.nih.gov/pubmed/18242379 (Pubitemid 351173269)
117. G.L. Chen, E.A. El-Gabry, and D.H. Bagley Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis J Urol 164 2000 1901 1904 http://www.ncbi.nlm.nih.gov/pubmed/11061876
118. S. Daneshmand, M.L. Quek, and J.L. Huffman Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience Cancer 98 2003 55 60 http://www.ncbi.nlm.nih.gov/pubmed/12833455 (Pubitemid 36741125)